SCHEMBL14192071

SCHEMBL14192071

Cc1c(C(=O)O)cnn1C1CCCCO1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
CYP4F2 P78329 3/20 0.44
CYP4A11 Q02928 3/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
ATR Q13535 5/20 0.40
GAA P10253 1/20 0.39
SPR P35270 1/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HCRTR1 O43613 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24746991 0.86 ALDH1A1 (0.44) ALDH1A1LMNAPOLBCYP4F2CYP4A11
SCHEMBL24747087 0.83 ALDH1A1 (0.47) ALDH1A1LMNAPOLBCYP4F2CYP4A11
SCHEMBL15286836 0.82 RXRA (0.44) ALDH1A1LMNAPOLBCYP4F2CYP4A11
SCHEMBL14903852 0.81 CYP4F2 (0.47) ALDH1A1LMNAPOLBCYP4F2CYP4A11
SCHEMBL574429 0.80 TRPV4 (0.43) ALDH1A1POLBSPRKDM4ECYP1A2
SCHEMBL16132481 0.80 CYP4F2 (0.49) ALDH1A1LMNAPOLBCYP4F2CYP4A11
SCHEMBL6052465 0.79 TRPV4 (0.45) ALDH1A1POLBSPRKDM4EHPGD
SCHEMBL24409154 0.78 CYP4F2 (0.50) ALDH1A1LMNAPOLBCYP4F2CYP4A11
SCHEMBL3402200 0.78 ALDH1A1 (0.46) ALDH1A1LMNAPOLBCYP4F2CYP4A11
SCHEMBL28851767 0.77 CYP4F2 (0.45) ALDH1A1LMNAPOLBCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed
US-20080114016-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114016-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, BUB1B ALDH1A1 2612/4885LMNA 2747/4885POLB 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.